Targeting the mevalonate pathway in multiple myeloma

被引：3
|
作者：
van der Spek, Ellen [1 ]
机构：
[1] Univ Med Ctr Utrecht, Dept Hematol, NL-3584 CX Utrecht, Netherlands
来源：
LEUKEMIA RESEARCH | 2010年 / 34卷 / 03期
关键词：
Multiple myeloma; Mevalonate pathway; Plasma cell lines; FPP; GGPP; CELL-LINES; DRUG-RESISTANCE; PLASMA-CELLS; APOPTOSIS; SIMVASTATIN; INHIBITOR; SURVIVAL; PROTEIN; GERANYLGERANYLATION; FARNESYLATION;
D O I：
10.1016/j.leukres.2009.07.027
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：267 / 268
页数：2
相关论文
共 50 条
  • [1] New treatment strategies for multiple myeloma by targeting BCL-2 and the mevalonate pathway
    van de Donk, NWCJ
    Bloem, AC
    van der Spek, E
    Lokhorst, HM
    CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (03) : 327 - 340
  • [2] Inhibition of the mevalonate pathway potentiates the effects of lenalidomide in myeloma
    van der Spek, Ellen
    Bloem, Andries C.
    Lokhorst, Henk M.
    van Kessel, Berris
    Bogers-Boer, Lijnie
    van de Donk, Niels W. C. J.
    LEUKEMIA RESEARCH, 2009, 33 (01) : 100 - 108
  • [3] Targeting the Isoprenoid Biosynthetic Pathway in Multiple Myeloma
    Haney, Staci L. L.
    Holstein, Sarah A. A.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (01)
  • [4] Targeting autophagy in multiple myeloma
    Zhuang Yun
    Jin Zhichao
    Yao Hao
    Ji Ou
    Yang Ran
    Dong Wen
    Shen Qun
    LEUKEMIA RESEARCH, 2017, 59 : 97 - 104
  • [5] Inhibitors of the mevalonate pathway as potential therapeutic agents in multiple myeloma
    Baulch-Brown, Cindy
    Molloy, Timothy J.
    Yeh, Sung Lin
    Ma, David
    Spencer, Andrew
    LEUKEMIA RESEARCH, 2007, 31 (03) : 341 - 352
  • [6] Targeting the Mevalonate Pathway in Cancer
    Juarez, Dennis
    Fruman, David A.
    TRENDS IN CANCER, 2021, 7 (06): : 525 - 540
  • [7] Targeting the Mevalonate Pathway for Treating Lung Cancer
    Fatehi Hassanabad, Ali
    Mina, Fady
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2020, 43 (01): : 69 - 70
  • [8] Exploiting the mevalonate pathway to distinguish statin-sensitive multiple myeloma
    Clendening, James W.
    Pandyra, Aleksandra
    Li, Zhihua
    Boutros, Paul C.
    Martirosyan, Anna
    Lehner, Richard
    Jurisica, Igor
    Trudel, Suzanne
    Penn, Linda Z.
    BLOOD, 2010, 115 (23) : 4787 - 4797
  • [9] Deregulation and Targeting of TP53 Pathway in Multiple Myeloma
    Jovanovic, Katarina K.
    Escure, Guillaume
    Demonchy, Jordane
    Willaume, Alexandre
    Van de Wyngaert, Zoe
    Farhat, Meryem
    Chauvet, Paul
    Facon, Thierry
    Quesnel, Bruno
    Manier, Salomon
    FRONTIERS IN ONCOLOGY, 2019, 8
  • [10] Selinexor: Targeting a novel pathway in multiple myeloma
    Mo, Clifton C.
    Yee, Andrew J.
    Midha, Shonali
    Hartley-Brown, Monique A.
    Nadeem, Omar
    O'Donnell, Elizabeth K.
    Bianchi, Giada
    Sperling, Adam S.
    Laubach, Jacob P.
    Richardson, Paul G.
    EJHAEM, 2023, 4 (03): : 792 - 810
12345